RESUMEN
OBJECTIVE: The challenge of pediatric brain tumor surgery is given due to a relative low prevalence but high heterogeneity in age, localization, and pathology. Improvements of long-term overall survival rates were achieved during the past decades stressing the importance of a multidisciplinary decision process guided by a national treatment protocol. We reviewed the entire spectrum of pediatric brain tumor surgeries from the perspective of an interdisciplinary pediatric neuro-oncology center in Germany. METHODS: Every patient who underwent brain tumor surgery from January 2010 to June 2017 in our Pediatric Neurosurgery department was retrospectively included and evaluated regarding the course of treatment. Perioperative data such as tumor localization, timing of surgery, extent of resection, neuropathological diagnosis, transfusion rates, oncologic and radiation therapy, and neurological follow-up including morbidity and mortality were evaluated. RESULTS: Two hundred ninety-three pediatric brain tumor patients were applicable (age: 8.28 ± 5.62 years, 1.22:1.0 m:f). A total of 531 tumor surgical interventions was performed within these patients (457 tumor resections, 74 tumor biopsies; mean interventions per patient 1.8 ± 1.2). Due to a critical neurologic status, 32 operations (6%) were performed on the day of admission. In 65.2% of all cases, tumor were approached supratentorially. Most frequent diagnoses of the cases were glial tumors (47.8%) and embryonal tumors (17.6%). Preoperative planned extent of resection was achieved in 92.7%. Pre- and postoperative neurologic deficits resolved completely in 30.7%, whereas symptom regressed in 28.6% of surgical interventions. New postoperative neurologic deficit was observed in 10.7%, which resolved or improved in 80% of these cases during 30 days. The mortality rate was 1%. CONCLUSION: We outlined the center perspective of a specialized pediatric neuro-oncological center describing the heterogeneous distribution of cases regarding age-related prevalence, tumor localization, and biology, which requires a high multidisciplinary expertise. The study contributes to define challenges in treating pediatric brain tumors and to develop quality indicators for pediatric neuro-oncological surgery. We assume that an adequate volume load of patients within a interdisciplinary infrastructure is warranted to aim for effective treatment and decent quality of life for the majority of long-term surviving pediatric tumor patients.
Asunto(s)
Neoplasias Encefálicas , Glioma , Adolescente , Niño , Preescolar , Humanos , Neoplasias Encefálicas/patología , Glioma/cirugía , Procedimientos Neuroquirúrgicos/métodos , Calidad de Vida , Estudios Retrospectivos , Resultado del TratamientoAsunto(s)
Endoscopía del Sistema Digestivo/métodos , Esofagitis/diagnóstico , Procesamiento de Imagen Asistido por Computador/métodos , Grabación en Video , Antiulcerosos/uso terapéutico , Endoscopía del Sistema Digestivo/instrumentación , Esofagitis/tratamiento farmacológico , Esofagitis/etiología , Reflujo Gastroesofágico/complicaciones , Reflujo Gastroesofágico/tratamiento farmacológico , Humanos , Masculino , Persona de Mediana Edad , Omeprazol/uso terapéuticoRESUMEN
Esophagitis has increasingly been implicated as a cause of chronic laryngitis and there is some evidence that gastro-esophageal reflux disease (GERD) is more common in patients with laryngitis. The aim of this study was to evaluate whether patients with esophagitis and laryngitis responded to treatment with omeprazole. Of 74 consecutive patients with endoscopically proven GERD, 21 had laryngitis. These 21 patients with associated esophagitis and chronic laryngitis were treated for 4 weeks with omeprazole 40 mg per day. After 2 weeks of treatment and at the conclusion of the study, 2 weeks later, esophagoscopy and laryngoscopy were performed and the patients responded to a questionnaire on their symptoms. The follow-up period was 1 year. Twenty-one of the 74 patients (28.4%) had esophagitis (grade I, n = 12; grade II, n = 9) and associated laryngitis (grade I, n = 14; grade II, n = 7). The severity of the esophagitis accorded with the severity of the laryngitis. After 2 weeks' treatment with omeprazole, both the esophageal and the laryngeal symptoms had improved in all 21 patients. Endoscopically, the healing rates were 62% for esophagitis and 33.3% for laryngitis. At the end of the study period, at 4 weeks, all patients were symptom-free and the esophagitis and laryngitis had healed completely. No patient suffered from drug-induced side effects. Patients with associated laryngitis and esophagitis should be given adequate anti-reflux therapy. Both the laryngeal and esophageal symptoms improved with the omeprazole treatment, suggesting that reflux was the underlying etiology.
Asunto(s)
Antiulcerosos/uso terapéutico , Esofagitis Péptica/tratamiento farmacológico , Reflujo Gastroesofágico/tratamiento farmacológico , Laringitis/tratamiento farmacológico , Omeprazol/uso terapéutico , Adulto , Anciano , Enfermedad Crónica , Esofagitis Péptica/complicaciones , Esofagitis Péptica/fisiopatología , Esofagoscopía , Femenino , Estudios de Seguimiento , Reflujo Gastroesofágico/complicaciones , Reflujo Gastroesofágico/fisiopatología , Humanos , Laringitis/complicaciones , Laringitis/fisiopatología , Laringoscopía , Masculino , Persona de Mediana Edad , Encuestas y Cuestionarios , Resultado del TratamientoRESUMEN
Suppression of acid secretion with omeprazole is highly effective for the healing of oesophagitis. The aims of the present study were to determine whether recovery of gastro-oesophageal reflux disease in patients with stricture improves dysphagia and decreases the dilatation need and to compare the efficacy of omeprazole versus H2-receptor antagonists. Thirty-eight patients with peptic stricture (grade IV oesophagitis) and erosive oesophagitis underwent endoscopic dilatation and were randomized to omeprazole (40 mg daily; n = 20) versus ranitidine (150 mg twice daily; n = 18). Healing was proven endoscopically and patients were interviewed for dysphagia relief. Patients were assessed for relapse by endoscopy 6 months later. The follow-up period was a further 6 months. Patients received maintenance treatment with 40 mg omeprazole daily or ranitidine 150 mg twice daily and the total duration of treatment was 1 year. At 6 months, omeprazole produced a highly significant (P < 0.0001) greater rate of oesophagitis healing and highly significant (P < 0.0001) fewer dilatations compared with H2-receptor antagonists (18 (90%) patients vs five (28%) patients, respectively; 3.5 vs 9.0 dilatations/patient). At 12 months, not one of the 18 successfully treated patients from the omeprazole group had relapsed. The two remaining patients required further dilatation and 40 and 60 mg omeprazole daily for healing. In comparison, all patients on ranitidine had to undergo further bougienage. In conclusion, omeprazole is a safe and effective maintenance treatment for preventing relapse of complicated reflux oesophagitis.
Asunto(s)
Antiulcerosos/uso terapéutico , Estenosis Esofágica/tratamiento farmacológico , Esofagitis Péptica/tratamiento farmacológico , Omeprazol/uso terapéutico , Antiácidos/uso terapéutico , Dilatación , Estenosis Esofágica/terapia , Femenino , Estudios de Seguimiento , Antagonistas de los Receptores H2 de la Histamina/uso terapéutico , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Ranitidina/uso terapéutico , Recurrencia , Factores de TiempoRESUMEN
The presentation of gastric ulcer healing taken from video endoscopy as a dynamic process could not be realized till now. The documentation of the dynamic healing process shattered either on the patient's compliance or on the inconstancy of the image cut due to wobbling. The replay should be performed as a time lapse whereby the picture disturbances would become an essential part.-Instead of presenting a continuous film, instant takes of ulcer healing were processed. A dynamic effect was produced by computer-assisted production of intermediate pictures. A video was created in which short video sequences in definite time intervals were recorded endoscopically. Single stills-so-called original pictures-fitting together from each sequence were selected and spliced together. The missing intermediate pictures were made with a special computer technique according to the mathematical concept of interpolation. With this technique, the dynamic documentation of gastric ulcer healing in a 47-year-old male patient was performed. The technique enables an almost natural and real observation of ulcer healing and promises new physiological and patho-physiological knowledge in gastroenterologic endoscopy.
Asunto(s)
Amoxicilina/uso terapéutico , Antiulcerosos/administración & dosificación , Gastroscopios , Infecciones por Helicobacter/tratamiento farmacológico , Helicobacter pylori , Procesamiento de Imagen Asistido por Computador/instrumentación , Omeprazol/administración & dosificación , Programas Informáticos , Úlcera Gástrica/tratamiento farmacológico , Grabación en Video/instrumentación , Cicatrización de Heridas/efectos de los fármacos , Sistemas de Computación , Quimioterapia Combinada , Infecciones por Helicobacter/diagnóstico , Infecciones por Helicobacter/fisiopatología , Humanos , Masculino , Persona de Mediana Edad , Úlcera Gástrica/diagnóstico , Úlcera Gástrica/fisiopatología , Cicatrización de Heridas/fisiologíaAsunto(s)
Enfermedades de la Corteza Suprarrenal/diagnóstico , Insuficiencia Suprarrenal/diagnóstico , Discitis/diagnóstico , Vértebras Torácicas , Tuberculosis Endocrina/diagnóstico , Tuberculosis Pulmonar/diagnóstico , Tuberculosis de la Columna Vertebral/diagnóstico , Diagnóstico Diferencial , Femenino , Humanos , Persona de Mediana Edad , Recurrencia , Vértebras Torácicas/patologíaRESUMEN
There is some evidence from anglo-american clinical and experimental studies that gastro-esophageal reflux is more common in patients with laryngitis. Within the framework of an open study, 32 patients with reflux esophagitis and laryngitis were treated with 20 mg omeprazole daily. After 4 weeks at the latest, in all cases inflammation of the esophagus and larynx had healed completely and the patients were without complaints. Suggesting that reflux is the underlying etiology patients with laryngitis seem to benefit from omeprazole.
Asunto(s)
Reflujo Gastroesofágico/complicaciones , Laringitis/etiología , Adulto , Anciano , Antiulcerosos/efectos adversos , Antiulcerosos/uso terapéutico , Enfermedad Crónica , Endoscopía del Sistema Digestivo , Femenino , Reflujo Gastroesofágico/tratamiento farmacológico , Humanos , Laringitis/tratamiento farmacológico , Masculino , Persona de Mediana Edad , Omeprazol/efectos adversos , Omeprazol/uso terapéuticoRESUMEN
Within the framework of a retrospective study complications of endoscopic variceal sclerotherapy were analyzed. From April, 1, 1988 till August, 31, 1994 267 consecutive patients (158 male, 109 female, mean age 43 [27-78] years) with esophageal variceal hemorrhage due to liver cirrhosis and portal hypertension underwent endoscopic variceal injection treatment. Sclerotherapy was performed with 24.5 ml (12-34 ml) 1% of polydocanole on average per treatment. Each patient had 4.5 (2-7) therapy sessions on average. Local complications were: Transient dysphagia (73%), chest pain (65%), esophageal ulcerations (63%), ulerogenic bleeding (14%), posttherapeutic hemorrhage (13%), esophageal strictures (10%), pleural effusions (9%), subfebrile temperatures (6.4%), pericarditis (0.4%) and esophageal perforation (0.4%). No patient died from sclerotherapy-induced side effects. In conclusion, endoscopic injection therapy is an efficient treatment of acute variceal hemorrhage. Not severe local complications often occur, severe side effects are extremely rare, however.
Asunto(s)
Várices Esofágicas y Gástricas/terapia , Hemorragia Gastrointestinal/terapia , Polietilenglicoles/efectos adversos , Soluciones Esclerosantes/efectos adversos , Escleroterapia/efectos adversos , Adulto , Anciano , Várices Esofágicas y Gástricas/etiología , Femenino , Hemorragia Gastrointestinal/etiología , Humanos , Hipertensión Portal/complicaciones , Cirrosis Hepática/complicaciones , Masculino , Persona de Mediana Edad , Polidocanol , Polietilenglicoles/administración & dosificación , Estudios Retrospectivos , Factores de Riesgo , Soluciones Esclerosantes/administración & dosificación , Resultado del TratamientoRESUMEN
Thirty-five patients with duodenal ulcer bleeding and Helicobacter pylori-colonization were assigned to receive 2 x 20 mg omeprazole and 3 x 750 mg amoxycillin daily for 2 weeks. Eradication was defined as no evidence of H. pylori infection by urease test and by histology 4 weeks after completion of therapy. Two patients were lost to follow up. All ulcers healed completely (100% ulcer healing rate). Twenty-nine out of the 33 patients were H. pylori-negative (87.9% eradication rate). Three patients complained of typical side effects of amoxycillin (9.1% side effect rate). The patients were prospectively followed for 12 months. After ulcer healing, no maintenance therapy was given. One of the 29 patients in whom H. pylori eradication had been successful suffered a second ulcer hemorrhage with H. pylori reinfection (3.4% relapse rate of ulcer bleeding), and this was managed endoscopically. Recurrent ulcer hemorrhage occurred in 2 out of 4 H. pylori-resistant patients. At the end of the follow-up period, of the patients in whom H. pylori eradication had been initially successful, only the patient with re-bleeding remained reinfected. The 4 H. pylori-resistant patients showed persistent H. pylori colonization. In conclusion, omeprazole plus amoxycillin is a safe and effective treatment for eradicating H. pylori; this treatment reduces the relapse rate of duodenal ulcer bleeding.
Asunto(s)
Amoxicilina/uso terapéutico , Úlcera Duodenal/tratamiento farmacológico , Infecciones por Helicobacter/tratamiento farmacológico , Omeprazol/uso terapéutico , Úlcera Péptica Hemorrágica/tratamiento farmacológico , Adulto , Anciano , Anciano de 80 o más Años , Amoxicilina/administración & dosificación , Recuento de Colonia Microbiana , Quimioterapia Combinada , Úlcera Duodenal/microbiología , Femenino , Infecciones por Helicobacter/fisiopatología , Helicobacter pylori/efectos de los fármacos , Helicobacter pylori/crecimiento & desarrollo , Humanos , Masculino , Persona de Mediana Edad , Omeprazol/administración & dosificación , Úlcera Péptica Hemorrágica/microbiología , Proyectos Piloto , Resultado del TratamientoAsunto(s)
Dolor en el Pecho/etiología , Disnea/etiología , Várices Esofágicas y Gástricas/terapia , Miocarditis/inducido químicamente , Pericarditis/inducido químicamente , Polietilenglicoles/efectos adversos , Escleroterapia/efectos adversos , Adulto , Ecocardiografía/efectos de los fármacos , Electrocardiografía/efectos de los fármacos , Humanos , Masculino , Miocarditis/complicaciones , Miocarditis/diagnóstico , Pericarditis/complicaciones , Pericarditis/diagnóstico , Polidocanol , Polietilenglicoles/administración & dosificaciónRESUMEN
The tragic death of a 26-year old hobby soccer player is described, who had a collision with the opposing goalie and suffered from a fracture of the left lateral process of the atlas, an extensive subarachnoid haemorrhage, tamponade of the third and fourth cerebral ventricles, bleeding into both lateral cerebral ventricles, infratentorial and supratentorial cerebral oedema. Furthermore, a survey of the literature concerning acute death in soccer is presented.
Asunto(s)
Traumatismos en Atletas/diagnóstico por imagen , Atlas Cervical/lesiones , Traumatismos Cerrados de la Cabeza/diagnóstico por imagen , Fútbol/lesiones , Fracturas de la Columna Vertebral/diagnóstico por imagen , Tomografía Computarizada por Rayos X , Adulto , Muerte Encefálica/diagnóstico por imagen , Edema Encefálico/diagnóstico por imagen , Atlas Cervical/diagnóstico por imagen , Resultado Fatal , Humanos , Masculino , Hemorragia Subaracnoidea/diagnóstico por imagenRESUMEN
OBJECTIVE: To investigate the effectiveness of prophylactic injection therapy in vascular malformations after acute hemorrhage. To review recent advances in diagnosis and treatment control of bleeding intestinal angiodysplasias with an endoscopic Doppler device. DESIGN: Open prospective study involving 34 patients with bleeding from gastroduodenal and colorectal angiodysplasias. INTERVENTIONS: In order to detect the superficial arterial vessels responsible for the bleeding, a total of 79 lesions were scanned by transendoscopic Doppler ultrasonography. 70 vascular ectasias (88.6%) were Doppler-positive and had injection therapy with epinephrine and polidocanol. RESULTS: Out of the 70 sclerosed angiodysplasias, 63% (90.0%) could not be found endoscopically 2 weeks later, confirming the success of therapy. Doppler noise was still recorded in 7 visible malformations, indicating insufficient treatment. Further injections were made into these lesions, and the vascular anomalies were finally eliminated. During 1 year of follow-up, 2 of the 34 treated patients (5.88%) relapsed with actively bleeding cecal angiodysplasias. After repeated endoscopic hemostasis, no more hemorrhage was observed in both patients. The results were partly published in previous publications. CONCLUSION: Endoscopic Doppler ultrasonography may help in identification and treatment of intestinal angiodysplasias. The technically simple method allows objective evaluation of the endoscopic findings and enables monitoring of local endoscopic therapy.
Asunto(s)
Angiodisplasia/diagnóstico por imagen , Hemorragia Gastrointestinal/diagnóstico por imagen , Ultrasonografía Doppler/instrumentación , Adulto , Anciano , Anciano de 80 o más Años , Angiodisplasia/tratamiento farmacológico , Epinefrina/administración & dosificación , Femenino , Estudios de Seguimiento , Hemorragia Gastrointestinal/tratamiento farmacológico , Humanos , Masculino , Persona de Mediana Edad , Polidocanol , Polietilenglicoles/administración & dosificación , EscleroterapiaAsunto(s)
Enfermedades del Esófago/tratamiento farmacológico , Omeprazol/uso terapéutico , Ranitidina/uso terapéutico , Escleroterapia/efectos adversos , Adulto , Anciano , Anciano de 80 o más Años , Resistencia a Medicamentos , Enfermedades del Esófago/etiología , Várices Esofágicas y Gástricas/terapia , Femenino , Hemorragia Gastrointestinal/terapia , Humanos , Masculino , Persona de Mediana Edad , Úlcera/tratamiento farmacológico , Úlcera/etiologíaRESUMEN
To evaluate whether eradication with omeprazole and amoxicillin results in a reduction of ulcer recurrence and rebleeding in patients with Helicobacter pylori-associated duodenal ulcer hemorrhage, patients with upper gastrointestinal hemorrhage from duodenal ulcers with stigmata of recent hemorrhage, a drop in hemoglobin level of more than 2 g/dL, and documented H. pylori infection (by rapid urease test and histologic findings) were randomly assigned to receive omeprazole, 40 mg every day, and amoxicillin, 1 g twice a day, (Group A) or omeprazole alone, 40 mg every day, (Group B) for 2 weeks. No maintenance antiulcer therapy was given. Patients underwent a second endoscopy 4 weeks after completion of therapy and were followed for 1 year. Endoscopy was performed again at the end of 1 year. All patients showed ulcer healing 4 weeks after completion of therapy. H. pylori eradication rates were 83% (Group A) and 5% (Group B) (p < .001). Ulcer recurrences were significantly lower in Group A (3/29 or 10%) than in Group B (9/22 or 41%; p < .05). Comparison of Group A patients with eradication and Group B patients without eradication also revealed a significant difference in rates of ulcer relapse (1/24 or 4% versus 9/21 or 43%; p < .01). Rebleeding occurred significantly less often in the dual therapy group than in the omeprazole group (0/29 versus 6/22 or 27%; p < .01). Eradication of H. pylori significantly reduces the rates of ulcer recurrence and rebleeding in patients with duodenal ulcer bleeding. Dual therapy with omeprazole and amoxicillin should be considered in all H. pylori-positive patients with hemorrhage from duodenal ulcers.
Asunto(s)
Amoxicilina/farmacología , Helicobacter pylori/efectos de los fármacos , Úlcera Péptica Hemorrágica/microbiología , Úlcera Péptica Hemorrágica/prevención & control , Adulto , Anciano , Anciano de 80 o más Años , Amoxicilina/administración & dosificación , Quimioterapia Combinada , Úlcera Duodenal/tratamiento farmacológico , Femenino , Humanos , Masculino , Persona de Mediana Edad , Omeprazol/administración & dosificación , Omeprazol/farmacología , RecurrenciaRESUMEN
Dieulafoy's disease is a gastric vascular malformation, which typically causes massive hemorrhage. The lesion is most often found in the proximal stomach, but has also been reported in the esophagus and in the small intestine. Three patients with esophageal Dieulafoy's anomaly and recurrent bleeding are reported. For the first time, transendoscopic Doppler ultrasound was used to identify arterial blood flow from the lesions. The ulcerations were treated by injection of adrenaline. Successful therapy resulted in the disappearance of arterial pulsations and no rebleeding occurred. Doppler-controlled endoscopic intervention should be the first line of treatment in the esophageal vessel stump.
Asunto(s)
Malformaciones Arteriovenosas/complicaciones , Esófago/irrigación sanguínea , Hemorragia Gastrointestinal/etiología , Adulto , Anciano , Malformaciones Arteriovenosas/diagnóstico por imagen , Malformaciones Arteriovenosas/terapia , Epinefrina/uso terapéutico , Femenino , Hemorragia Gastrointestinal/terapia , Humanos , Masculino , Persona de Mediana Edad , Ultrasonografía DopplerRESUMEN
The case of a 78 years old patient with impressive flush symptoms is reported. 5-Hydroxyindoleacetic acid and serotonin were elevated. The responsible pathomorphological structure is a 8 x 4.5 x 6 cm ileocaecal neoplasm. Pre-, intra- and postoperatively liver metastases could not be detected during a 18 month period. After surgery of the carcinoid flush disappeared, so that the tumour seize resulting in enormous secretion of metabolites with endocrine activity should be claimed responsible for causing this symptom.
Asunto(s)
Neoplasias del Ciego/diagnóstico , Rubor/etiología , Neoplasias del Íleon/diagnóstico , Neoplasias Hepáticas/secundario , Síndrome Carcinoide Maligno/diagnóstico , Anciano , Neoplasias del Ciego/patología , Neoplasias del Ciego/cirugía , Ciego/patología , Diagnóstico Diferencial , Humanos , Ácido Hidroxiindolacético/sangre , Neoplasias del Íleon/patología , Neoplasias del Íleon/cirugía , Íleon/patología , Mucosa Intestinal/patología , Hígado/patología , Neoplasias Hepáticas/patología , Masculino , Síndrome Carcinoide Maligno/patología , Síndrome Carcinoide Maligno/cirugía , Serotonina/sangre , Tomografía Computarizada por Rayos XRESUMEN
An unusual case of a 25-year-old male Italian is reported. The patient endured an acute hepatitis without detectable HBs-antigen by coinfection with hepatitis-B and Delta. Coincidently, a cured hepatitis-C was present. Firstly hepatitis-B-virus DNA could be demonstrated in a small quantity by serodiagnosis (6 pg/ml, hybridization technique). Subsequently, the identification of B-virus DNA was only possible in liver tissue (PCR-technique), but no longer by serodiagnosis. The probable enduring inhibition of hepatitis-B-virus replication by Delta virus resulted in a self limitation of the disease within 2 months (HDV-RNA negative, HBs-Ag and HBe-Ag negative; Anti-HBs negative, Anti-HBe and Anti-HBc positive). In spite of negativation of replication markers for hepatitis-B a subsequent reactivation of the infection was possible by viral material which persisted in liver tissue.
Asunto(s)
Antígenos de Superficie de la Hepatitis B/análisis , Hepatitis B/diagnóstico , Hepatitis D/diagnóstico , Enfermedad Aguda , Adulto , Hepatitis B/inmunología , Virus de la Hepatitis B/genética , Hepatitis C/diagnóstico , Hepatitis C/inmunología , Hepatitis D/inmunología , Virus de la Hepatitis Delta/genética , Humanos , Masculino , Reacción en Cadena de la Polimerasa/métodosRESUMEN
METHOD: Within the framework of an open prospective study, 47 patients with chronic reflux esophagitis, unresponsive to H2-receptor blockers and complicated by stenosis, underwent endoscopic bougienage. Unsuccessful treatment with H2-receptor blockers was followed in all patients by antisecretion treatment with omeprazole at a dose of 40 mg/day. RESULTS: At the latest after 3 months, stenotic and inflammatory changes had cleared up in all patients and under continued omeprazole over the long-term, remission of at least one year was achieved. CONCLUSION: A combination of endoscopic bougienage and simultaneous treatment with the proton pump blocker, omeprazole, represents effective treatment of chronic reflux disease complicated by stenosis.